COMPASS is Genoptix’s proprietary diagnostic approach for hematologic cancers. COMPASS provides a comprehensive assessment and clinically actionable results by assigning an expert hematopathologist to manage the diagnostic workflow. Biomarker test results from diverse technologies are synthesized into a single streamlined diagnosis for oncologists.
CHART is our industry-leading serial reporting service that maps your members’ disease progression and assessment of residual disease over time, enabling physicians to accurately assess response to therapy. By providing clear and confident answers from the start, COMPASS and CHART save time and money while improving outcomes.
POWERFUL MOLECULAR PROFILES
Our molecular profiles for myeloid diseases (MMP), myelodysplastic syndromes (MDS), and acute myeloid leukemia (AML) provide improved risk stratification and understanding of underlying disease mechanism, so oncologists can tailor effective treatment plans for your members. As a Next-Generation Sequencing (NGS) center of excellence, our precise molecular profiles help patients receive the most appropriate targeted therapy and the best possible care.